These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2930538)

  • 1. Neutralization of cholera toxin by rat IgA secretory antibodies induced by a free synthetic peptide.
    Delmas A; Gruaz-Guyon A; Pedoussaut S; Pierre P; Rivaille P; Vaerman JP
    Biochem Biophys Res Commun; 1989 Mar; 159(2):707-12. PubMed ID: 2930538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of rat secretory IgA antibodies against cholera toxin by a synthetic peptide.
    Jacob CO; Vaerman JP
    Immunology; 1986 Sep; 59(1):129-33. PubMed ID: 3019874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholera toxin neutralization: a comparison of purified serum IgG and biliary secretory IgA antibodies.
    Pierre P; Langendries A; Vaerman JP
    Immunol Lett; 1988 May; 18(1):51-5. PubMed ID: 3378829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunization with a free peptide from cholera toxin: local protection and IgA production.
    Pedoussaut S; Delmas A; Milhaud G; Rivaille P; Gruaz-Guyon A
    Mol Immunol; 1989 Feb; 26(2):115-9. PubMed ID: 2918857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of cholera toxin by rat bile secretory IgA antibodies.
    Vaerman JP; Derijck-Langendries A; Rits M; Delacroix D
    Immunology; 1985 Mar; 54(3):601-3. PubMed ID: 3918935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA antibodies in rat bile inhibit cholera toxin-induced secretion in ileal loops in situ.
    Tamaru T; Brown WR
    Immunology; 1985 Aug; 55(4):579-83. PubMed ID: 4018842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera toxin-induced fluid secretion in rat gut ligated loops: influence of bile from normal or cholera toxin-immunized rats.
    Pierre PG; Solbreux P; Vaerman JP
    Immunology; 1989 Nov; 68(3):319-24. PubMed ID: 2592008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
    Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
    J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge.
    Lycke N; Bromander AK; Holmgren J
    Int Arch Allergy Appl Immunol; 1989; 88(3):273-9. PubMed ID: 2785966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.
    Chen KS; Strober W
    Eur J Immunol; 1990 Feb; 20(2):433-6. PubMed ID: 2311649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune function in transplanted small intestine. Total secretory IgA production and response against cholera toxin.
    Xia WY; Kirkman RL
    Transplantation; 1990 Feb; 49(2):277-80. PubMed ID: 2305456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
    Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
    J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response related to the molecular structure of a peptide from the cholera toxin B subunit.
    Halimi H; Rivaille P
    Vaccine; 1993 Sep; 11(12):1233-9. PubMed ID: 7504858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
    Gärdby E; Lycke NY
    Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection.
    Lycke N; Erlandsson L; Ekman L; Schön K; Leanderson T
    J Immunol; 1999 Jul; 163(2):913-9. PubMed ID: 10395687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
    Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
    Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of the secretory IgA response to Toxoplasma gondii using cholera toxin.
    Bourguin I; Chardes T; Mevelec MN; Woodman JP; Bout D
    FEMS Microbiol Lett; 1991 Jul; 65(3):265-71. PubMed ID: 1916225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.